MedPath

A community-based study of prevalence of skin disorders in semi-urban and urban Telangana State

Not Applicable
Registration Number
CTRI/2022/12/048189
Lead Sponsor
Pfizer Inc
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects age 2 years and above

2.Subjects who have skin disorders

3.Able to provide informed consent/ assent (in case of children).

4.Subjects who reside in the study area (for at least 6 months)

Exclusion Criteria

1.Subjects with no skin disorders.

2.Subjects below the age of 2 years

3.Subjects unable to participate in study related procedures

4.Subjects unwilling or unable to provide informed consent/assent

5.Subjects who do not reside in the area (at 6 months) and/or are unlikely to reside in the area until end of December 2023

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
we aim to determine the prevalence of skin disorders in urban and semi urban communities and their impact on quality of life.Timepoint: 12 to 13 months
Secondary Outcome Measures
NameTimeMethod
â?¢To determine impact on quality of life due to skin disorders <br/ ><br>â?¢To explore influence of predisposing conditions including influence of geography on skin disorders and quality of lifeTimepoint: 12 to 13 months
© Copyright 2025. All Rights Reserved by MedPath